Atai Life Sciences Current Ratio 2020-2023 | ATAI
Atai Life Sciences Current Ratio Historical Data | |||
---|---|---|---|
Date | Current Assets | Current Liabilities | Current Ratio |
2023-12-31 | $0.19B | $0.02B | 9.22 |
2023-09-30 | $0.22B | $0.02B | 10.96 |
2023-06-30 | $0.24B | $0.02B | 13.54 |
2023-03-31 | $0.27B | $0.02B | 13.43 |
2022-12-31 | $0.29B | $0.02B | 14.43 |
2022-09-30 | $0.32B | $0.03B | 12.25 |
2022-06-30 | $0.32B | $0.02B | 14.74 |
2022-03-31 | $0.35B | $0.02B | 15.79 |
2021-12-31 | $0.38B | $0.02B | 17.92 |
2021-09-30 | $0.44B | $0.02B | 28.85 |
2021-06-30 | $0.46B | $0.01B | 32.26 |
2021-03-31 | $0.13B | $0.02B | 6.88 |
2020-12-31 | $0.10B | $0.01B | 8.10 |
2020-09-30 | $0.00B | 0.00 | |
2020-06-30 | $0.00B | 0.00 | |
2020-03-31 | $0.00B | 0.00 | |
2019-12-31 | $0.04B | $0.00B | 24.36 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical - Outpatient & Home Care | $0.317B | $0.000B |
atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Fresenius SE (FSNUY) | Germany | $15.884B | 9.61 |
Quest Diagnostics (DGX) | United States | $13.983B | 14.46 |
DaVita (DVA) | United States | $11.060B | 15.05 |
Chemed (CHE) | United States | $9.031B | 28.42 |
Encompass Health (EHC) | United States | $7.873B | 21.60 |
Elanco Animal Health (ELAN) | United States | $6.690B | 15.25 |
Option Care Health (OPCH) | United States | $5.371B | 21.02 |
RadNet (RDNT) | United States | $3.260B | 95.22 |
Amedisys (AMED) | United States | $2.966B | 21.16 |
LifeStance Health (LFST) | United States | $2.174B | 0.00 |
Astrana Health (ASTH) | United States | $2.056B | 25.94 |
Addus HomeCare (ADUS) | United States | $1.577B | 24.17 |
U.S Physical Therapy (USPH) | United States | $1.469B | 38.08 |
Pennant (PNTG) | United States | $0.604B | 34.90 |
Aveanna Healthcare Holdings (AVAH) | United States | $0.416B | 0.00 |
Daxor (DXR) | United States | $0.046B | 0.00 |
MEDIROM Healthcare Technologies (MRM) | Japan | $0.029B | 0.00 |
ATI Physical Therapy (ATIP) | United States | $0.017B | 0.00 |
Psychemedics (PMD) | United States | $0.015B | 0.00 |
Novo Integrated Sciences (NVOS) | United States | $0.009B | 0.00 |
Ontrak (OTRK) | United States | $0.008B | 0.00 |
IMAC Holdings (BACK) | United States | $0.004B | 0.00 |